[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Page 28235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11345]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Novel Imaging Agents to Expand the Clinical Toolkit for
Cancer Diagnosis, Staging, and Treatment.
Date: May 29, 2013.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, 9609 Medical Center Drive,
Room 4W034, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Sonya Roberson, Ph.D., Health Scientist
Administrator, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W116, Bethesda, MD 20892-8328, 240-276-6347,
[email protected].
This notice is being published less than 15 days prior to the
meeting date due to scheduling conflicts.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Cancer Theranostics II.
Date: June 3, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 9609 Medical Center Drive,
Room 7W030, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Savvas C Makrides, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Bethesda, MD 20892-8328, 240-276-6374,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Companion Diagnostics--Phase II.
Date: June 5, 2013.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 9609 Medical Center Drive,
Room 7W032, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W234, Bethesda, MD 20892-8328, 240-276-6368,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Pharmacodynamic Assays TX2 of 2.
Date: June 6, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, 9609 Medical Center Drive,
Room 7W034, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Thomas M Vollberg, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Bethesda, MD 20892-8328, 240-276-6341,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Biosensors for Early Cancer Detection and Risk Assessment.
Date: June 10, 2013.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 9609 Medical Center Drive,
Room 6W032, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 9609 Medical Center Drive,
Room 7W244, Bethesda, MD 20892-8329, 240-276-6373,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Radioprotector/Mitigator Development to Decrease Normal
Tissue Injury During Radiotherapy.
Date: June 13, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W302, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific
Review Officer, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Development of a Molecular Diagnostic Assay to Detect Basal-
like Breast Cancer.
Date: June 13, 2013.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 9609 Medical Center Drive,
Room 6W032, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Sonya Roberson, Ph.D., Health Scientist
Administrator, Resources and Training Review Branch, Division Of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W116, Bethesda, MD 20892-8328, 240-276-6347,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Process Analytic Technologies (PAT) for Biologics: Innovative
Methods for Monitoring and Analyzing Product Quality.
Date: June 19, 2013.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 9609 Medical Center Drive,
Room 2W034, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W268, Bethesda, MD 20892-8328, 240-276-6386,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-11345 Filed 5-13-13; 8:45 am]
BILLING CODE 4140-01-P